New Delhi, Jun 14 (PTI) Novavax Inc, which has a vaccine manufacturing agreement with Serum Institute of India, on Monday said its COVID-19 vaccine candidate was highly effective with 90.4 per ...

New Delhi, Jun 8 (PTI) Emerging as the lowest bidder, Serum Institute of India's (SII) quoted price for each dose of inactivated polio vaccine to be procured under the routine immunization ...

.Lucknow, Uttar Pradesh, India
(Photo credit: PTI)

  • The complaint was filed by a Lucknow-based man Pratap Chandra 
  • He accused Serum Insititute's Adar Poonawalla of fraud
  • The complaint named ICMR director-general Dr Balram Bhargava too

St. Petersburg (Russia), Jun 5 (PTI) As Indian companies get ready to manufacture Russian-made Sputnik V anti-COVID vaccine to meet the staggering demand in the country, Russian President ...

.New Delhi, Delhi, India
Adar Poonawalla's SII has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology for developing Sputnik V. (Photo credit: PTI)

  • Sputnik V vaccine is currently being manufactured by Dr Reddy's Laboratories in India
  • SII had submitted an application to the DCGI on Thursday
  • SII plans to seek restricted emergency use permission of the Sputnik V in the country

New Delhi, Jun 4 (PTI) Serum Institute of India CEO Adar Poonawalla on Friday thanked US President Joe Biden and External Affairs Minister S Jaishankar for a policy change that will boost the ...

New Delhi, June 3 (PTI) Domestic vaccine major Serum Institute of India is seeking indemnity from liability for its COVID vaccines, saying that the rules should be same for all the ...

New Delhi, Jun 3 (PTI) The Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture the Sputnik V COVID-19 vaccine for ...

The Biological E-made vaccine uses recombinant-protein technology. (Photo credit: Representational: Unsplash)

  • Biological E Limited is India's oldest private vaccine maker
  • Centre will procure 30 crore vaccine doses from Biological E 
  • The vaccines are currently in Phase 3 trial

.New Delhi, Delhi, India
India is currently using made-in-India COVID-19 vaccines, Covishield manufactured by SII and Covaxin of Bharat Biotech. (Photo Credit: PTI)

  • Serum Institute of India (SII) earlier told that its employees had been working continually
  • Earlier, SII told that Covishield production would be ramped up to 6.5 crores in June, seven crores in July